Fasting plasma glucose versus glucose challenge test: screening for gestational diabetes and cost effectiveness.

Department of Obstetrics and Gynecology, Sainte-Justine Hospital, Montreal, QC, H3T 1C5, Canada.
Clinical Biochemistry (Impact Factor: 2.23). 10/2004; 37(9):780-4. DOI: 10.1016/j.clinbiochem.2004.05.018
Source: PubMed

ABSTRACT To compare the performance in screening for gestational carbohydrate intolerance of the 1-h 50-g glucose challenge test (GCT), fasting plasma glucose (FPG) and fasting capillary glucose (FCG).
FPG and FCG were measured at the same time as the GCT in 188 women. Gestational carbohydrate intolerance was diagnosed according to the Canadian Diabetes Association criteria. We constructed receiver operator characteristic (ROC) curves and compared the sensitivity and specificity of the FPG, FCG and GCT.
Gestational diabetes was diagnosed in 11.2% women and gestational impaired glucose tolerance in 8.4%. The areas under the ROC curves for the FPG, the GCT and the FCG were not statistically different (P = 0.26). The GCT yielded a better specificity than the FPG and the FCG for a comparable level of sensitivity.
The GCT is better than the FPG in our population and is cost effective.

  • Article: In reply.
    Obstetrics and Gynecology 02/2013; 121(2 Pt 1):377-8. DOI:10.1097/AOG.0b013e318280635e · 4.37 Impact Factor
  • Obstetrics and Gynecology 02/2013; 121(2 Pt 1):377. DOI:10.1097/AOG.0b013e318280e05d · 4.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To assess different diagnostic thresholds for gestational diabetes on outcomes for mothers and their offspring in the absence of treatment for gestational diabetes. This information was used to inform a National Institutes of Health consensus conference on diagnosing gestational diabetes. We searched 15 electronic databases from 1995 to May 2012. Study selection was conducted independently by two reviewers. Randomized controlled trials or cohort studies were eligible if they involved women without known pre-existing diabetes mellitus and who did not undergo treatment for gestational diabetes. One reviewer extracted, and a second reviewer verified, data for accuracy. Two reviewers independently assessed methodological quality. Thirty-eight studies were included. Three large, methodologically strong studies showed a continuous positive relationship between increasing glucose levels and the incidence of Caesarean section and macrosomia. When data were examined categorically (i.e. women meeting or not meeting specific diagnostic thresholds), women with gestational diabetes across all glucose criteria had significantly more Caesarean sections, shoulder dystocia, macrosomia (except for International Association of Diabetes in Pregnancy Study Groups' criteria) and large for gestational age. Higher glucose thresholds did not consistently demonstrate greater risk for all outcomes. Higher glucose thresholds did not consistently demonstrate greater risk, possibly because studies did not compare mutually exclusive groups of women. A pragmatic approach for diagnosis of gestational diabetes using Hyperglycemia and Adverse Pregnancy Outcome Study odds ratio 2.0 thresholds warrants further consideration until additional analysis of the data comparing mutually exclusive groups of women is provided and large randomized controlled trials investigating different diagnostic and treatment thresholds are completed.
    Diabetic Medicine 03/2014; 31(3):319-31. DOI:10.1111/dme.12357 · 3.06 Impact Factor